{
    "2020-09-06": [
        [
            {
                "time": "",
                "orginal_text": "医药生物行业：去伪存真",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "去伪存真"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "医药行业周报：板块回调 关注估值切换带来低估值板块投资机遇",
                "features": {
                    "keywords": [
                        "医药",
                        "板块回调",
                        "估值切换",
                        "低估值",
                        "投资机遇"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "医药生物行业周报：国产创新药频繁授权海外 继续重点推荐创新药产业链",
                "features": {
                    "keywords": [
                        "医药",
                        "生物",
                        "国产创新药",
                        "授权海外",
                        "创新药产业链"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "医药行业每周医览药闻：2020年医药中报业绩总结：后疫情时代 关注需求复苏下蕴含的全球市场机会",
                "features": {
                    "keywords": [
                        "医药",
                        "中报业绩",
                        "后疫情时代",
                        "需求复苏",
                        "全球市场机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}